Search results for "RC799-869"

showing 10 items of 72 documents

Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive an…

2019

Background:Linaclotide is approved for the treatment of moderate-to-severe irritable bowel syndrome (IBS) with constipation (IBS-C) in adults. This study aimed to assess factors predictive of a clinical response and improvements in non-IBS symptoms with linaclotide treatment in a Spanish patient population.Methods:In this open-label phase IIIb study, patients with moderate-to-severe IBS-C received linaclotide 290 μg once daily for 12 weeks. The primary endpoint was clinical response at week 12, defined as >30% reduction in IBS symptom severity score (IBS-SSS) or IBS-SSS <75 plus self-reported response of feeling ‘better’ or ‘much better’ versus the baseline. Digestive nonintestinal an…

Abdominal painmedicine.medical_specialtyConstipation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinefunctional gastrointestinal diseasesmedicinelcsh:RC799-869LinaclotideIrritable bowel syndromeOriginal Researchirritable bowel syndromebusiness.industryGastroenterologyabdominal painconstipationmedicine.diseasechemistry030220 oncology & carcinogenesisSustained response030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. Gastroenterologymedicine.symptombusinessTherapeutic Advances in Gastroenterology
researchProduct

Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

2019

Abstract Background Antiviral treatment for chronic hepatitis B (CHB) is largely unavailable in sub-Saharan Africa; hence, little is known about the prognosis after initiating treatment in African CHB patients. In this study we aimed to assess predictors of mortality in one of the largest CHB cohorts in sub-Saharan Africa. Methods Two-hundred-and-seventy-six CHB patients who started treatment with tenofovir disoproxil fumarate at a public hospital in Ethiopia between March 18, 2015, and August 1, 2017, were included in this analysis. Patients were followed up until October 1, 2017, and deaths were ascertained through hospital records and telephone interview with relatives. Decompensated cir…

AdultLiver CirrhosisMalemedicine.medical_specialtyTime FactorsSurvivalAdolescentEpidemiologyPhysical examinationAntiviral therapyAntiviral AgentsBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineHepatitis B ChronicInterquartile rangeRisk FactorsInternal medicineEpidemiologyMedicineHumansProspective Studieslcsh:RC799-869Prospective cohort studyTenofovirProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryHazard ratioGastroenterologyAge FactorsGeneral MedicineHepatitis BHepatologyMiddle Agedmedicine.diseaseHepatitis BResource-limited settingsSurvival RateVDP::Medisinske Fag: 700::Helsefag: 800030220 oncology & carcinogenesislcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyFemaleEthiopiabusinessBody mass indexResearch Article
researchProduct

High Seroprevalence of Autoantibodies Typical of Autoimmune Liver Disease in Eastern Ethiopia: Is Chewing of Khat (Catha edulis) a Triggering Factor?

2018

Background. Recent studies have identified chewing of khat (Catha edulis) as an independent risk factor for liver injury; however, the pathogenetic mechanism remains poorly understood. Case series have found markers of autoimmune hepatitis in patients with khat-related liver disease, suggesting that khat chewing might trigger an autoimmune response. The aims of the present study were (i) to assess the prevalence of autoantibodies typical for autoimmune liver diseases in a healthy population in Ethiopia and (ii) to explore the hypothesis that khat usage triggers autoimmunity. Methods. Consenting adults (≥18 years) without known autoimmune disease or manifest liver disease were included. One-…

AdultMale0301 basic medicinemedicine.medical_specialtyArticle SubjectPopulationCathaAutoimmune hepatitisYoung Adult03 medical and health sciencesLiver disease0302 clinical medicineRisk FactorsSeroepidemiologic StudiesKhatInternal medicinemedicineHumansSeroprevalenceRisk factorlcsh:RC799-869educationAutoantibodiesAutoimmune diseaseeducation.field_of_studyHepatologybiologybusiness.industryGastroenterologyAutoantibodyGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationHepatitis Autoimmune030104 developmental biologyCase-Control StudiesMasticationFemale030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologyEthiopiaChemical and Drug Induced Liver InjurybusinessResearch ArticleCanadian Journal of Gastroenterology and Hepatology
researchProduct

Psychopharmacology treatment and psychological interventions in irritable bowel syndromel

2013

Irritable bowel syndrome (IBS) accounts for 25% of gastroenterology output practice, making it one of the most common disorders in this practice. Psychological and social factors may affect the development of this chronic disorder. Furthermore, psychiatric symptoms and psychiatric diseases are highly prevalent in this condition, but the approach to treating these is not always straightforward. As emphasized in the biopsychosocial model of IBS, with regard to the modulatory role of stress-related brain-gut interactions and association of the disease with psychological factors and emotional state, it proves useful to encourage psychopharmacological treatments and psychosocial therapies, both …

Biopsychosocial modelmedicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyAlternative medicinePsychological interventionDiseaseReview ArticleAffect (psychology)medicine.diseaseChronic disorderspsychopharmacological treatment. psychological interventions. irritable bowel diseasemedicinelcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869PsychiatrybusinessPsychosocialIrritable bowel syndrome
researchProduct

13C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application

2017

Assessment of the liver function, and the need of constant monitoring of the organ’s capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. Most commonly, the diagnostics is based on measurements of static biochemical parameters, which allow us to draw conclusions only indirectly about the function and the degree of damage of the organ. On the other hand, liver biopsy is an invasive procedure and therefore it is associated with a considerable risk of complications. Dynamic tests enable us to assess quantitatively the organ’s functional reserve by analyzing the kinetics of the metabolization of the substr…

Breath testmedicine.medical_specialtyPathologyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReview ArticleGastroenterology03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisLiver biopsyInternal medicinemedicineMicrosomelcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyLiver functionlcsh:RC799-869businessGastroenterology Research and Practice
researchProduct

The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection

2010

Natural history of HCV related chronic hepatitis is influenced and modified by many factors: virus features, coinfections and host characteristics. In particular, a peculiar genetic background of the host by conditioning the occurrence of intracellular metabolic derangements (i.e., insulin resistance) might contribute to accelerate the rate of progression to cirrhosis and eventually the occurrence of hepatocellular carcinoma (HCC) and death. Likely, direct interplays between virus genotype and host genetic background might be hypothesized at this level. Morbidity and mortality in cirrhosis is primarily associated with complications of liver cirrhosis (ascites, hepatic encephalopathy, jaundi…

CirrhosisHepatologybusiness.industryReview ArticleJaundicemedicine.diseaseVirusdigestive system diseasesHCV therapy natural historyInsulin resistanceInterferonHepatocellular carcinomaImmunologyAscitesmedicinelcsh:Diseases of the digestive system. Gastroenterologymedicine.symptomlcsh:RC799-869businessHepatic encephalopathymedicine.drugInternational Journal of Hepatology
researchProduct

A Strange Case of Left Bowel Ischemia after Right Hernioplasty

2010

We report the first observed case of a young man who suffered of large and unsuspected left bowel ischemia following an elective right open hernioplasty. A 54-year-old man had a 2-year history of right inguinal reducible mass and was admitted to hospital for an elective day case open inguinal hernioplasty for a direct right inguinal hernia. Apart from mild hypertension controlled with ACE inhibitor, he was medically fit and well. The patient was submitted to open tension-free mesh repair with polypropylene preshaped mesh with local infiltration anesthesia and additive sedation with midazolam. The local anesthesia and surgery were uneventful and he was discharged home on the same day as per …

Colonic ischemiamedicine.medical_specialtyComplicationsGroinbusiness.industrymedicine.medical_treatmentGeneral surgeryInguinal herniaGastroenterologymedicine.diseaseHernia repairAsymptomaticSurgeryPublished: February 2010Inguinal herniamedicine.anatomical_structureMedicineHerniaLocal anesthesialcsh:Diseases of the digestive system. Gastroenterologymedicine.symptomlcsh:RC799-869ComplicationbusinessAtrial flutterCase Reports in Gastroenterology
researchProduct

Small Bowel Enteroscopy − A Joint Clinical Guideline from the Spanish and Portuguese Small Bowel Study Groups

2020

The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel diseases. A panel of experts selected by the Spanish and Portuguese small bowel study groups reviewed the available evidence focusing on the main indications of this technique, its role in the management algorithm of each indication and on its diagnostic and therapeutic yields. A set of recommendations were issued accordingly.Estas recomendações baseadas na evidência detalham o uso da enteroscopia assistida por dispositivo no manejo clínico das doenças do intestino delgado. Um conjunto de Gastrenterologistas diferenciados em patologia do intestino delgado foi selecion…

EnteroscopyStudy groupsmedicine.medical_specialtyAngioectasiaenteroscopycapsule endoscopydevice-assisted enteroscopyGuidelines03 medical and health sciences0302 clinical medicineangioectasiasmall bowelMedicineMedical physicsCapsule endoscopylcsh:RC799-869General Environmental Sciencebusiness.industryGastroenterologyGuidelinelanguage.human_language3. Good healthManagement algorithm030220 oncology & carcinogenesislanguageGeneral Earth and Planetary Sciences030211 gastroenterology & hepatologyDevice-assisted enteroscopylcsh:Diseases of the digestive system. GastroenterologyPortuguesebusinessSmall bowel Enteroscopy
researchProduct

Early diagnosis of colorectal cancer. Diagnostic delay reduction or rather screening programs?

2006

Gynecologymedicine.medical_specialtyTime Factorsbusiness.industryGastroenterologyGeneral MedicinePrognosisUnited KingdomSurvival RatemedicineDisease ProgressionHumansMass Screeninglcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869businessColorectal NeoplasmsRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
researchProduct

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

2021

[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.

Hepatocellular carcinomaLCmedicine.medical_treatment:diagnóstico::toma de decisiones clínicas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]NursesRC799-869Liver transplantationCholangiocarcinomaClinical trialsENS-CCAInterquartile rangeDecisió Presa dePandemic:Other subheadings::/diagnosis [Other subheadings]:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]CERO-19Pandèmia de COVID-19 2020-Immunology and AllergyiCCA intrahepatic cholangiocarcinomaCOVID-19 coronavirus disease 2019Liver Cancer Outcome in the COVID-19-pandemic ProjectSettore MED/12 - Gastroenterologiaddc:617IQRGastroenterologyBCLC Barcelona Clinic Liver Cancer:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]:neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas [ENFERMEDADES]Diseases of the digestive system. GastroenterologyManagementClinical PracticeClinical trialEuropean Network for the Study of Cholangiocarcinoma:Diagnosis::Clinical Decision-Making [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Fetge - Malalties - DiagnòsticInterquartile rangeLiver cancerLiver cancerPROGRESSION-FREE SURVIVALLiver Cancermedicine.medical_specialtyCoronavirus disease 2019 (COVID-19):Otros calificadores::/diagnóstico [Otros calificadores]610 Medicine & health:Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms [DISEASES]LT liver transplantationArticleBarcelona Clinic Liver CancerInternal MedicinemedicineENS-CCA European Network for the Study of CholangiocarcinomaHepatologybusiness.industryCERO-19 Liver Cancer Outcome in the COVID-19-pandemic ProjectCOVID-19IQR Interquartile rangemedicine.diseaseBCLCClinical trialEmergency medicineObservational study610 Medizin und GesundheitbusinessHCC hepatocellular carcinomaLC liver cancerSARS-CoV-2 severe acute respiratory syndrome coronavirus-2
researchProduct